About Nathan Hunkapiller
Form D filings for Curve Biosciences in 2024 list Nathan Hunkapiller as executive officer.
Nathan Hunkapiller first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Nathan Hunkapiller in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nathan Hunkapiller works with at each company, as listed on that company's latest Form D.
Curve Biosciences, Inc. · Form D, May 13, 2024
CO
Chuba Oyolu
Executive officer
SW
Shan Xiang Wang
Executive officer and director
TK
Themasap Khan
Director
RP
Ritish Patnaik
Chief Executive Officer and director